These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32404917)

  • 21. Plasmapheresis for neurological disorders.
    Schröder A; Linker RA; Gold R
    Expert Rev Neurother; 2009 Sep; 9(9):1331-9. PubMed ID: 19769448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic Apheresis in Immunologic Renal and Neurological Diseases.
    Bambauer R; Latza R; Burgard D; Schiel R
    Ther Apher Dial; 2017 Feb; 21(1):6-21. PubMed ID: 28078733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Turkish experience with therapeutic plasma exchange: A national survey.
    Korkmaz S; Solmaz Medeni S; Demirkan F; Kalayoglu Besisik S; Altay Dadin S; Akgun Cagliyan G; Kabukcu Hacioglu S; Sari I; Goren Sahin D; Arat M; Dagdas S; Ozet G; Kutlu N; Karaagac Akyol T; Ozcebe OI; Uskudar Teke H; Kiper Unal D; Guner N; Tombak A; Celik H; Bay I; Kiki I; Ozgur G; Erkurt MA; Ozatli D; Meletli O; Demircioglu S; Demir C; Kurtoglu E; Vural F; Tobu M; Karakus A; Ayyildiz O; Dal MS; Afacan Ozturk B; Albayrak M; Ocakci S; Bolaman Z; Sonmez M; Karakus V; Gokmen Sevindik O; Berber I; Dogu MH; Gulturk E; Ulas T; Payzin B; Kuku I; Cagirgan S; Altuntas F
    Transfus Apher Sci; 2019 Jun; 58(3):287-292. PubMed ID: 31036516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety of Therapeutic Apheresis in Children and Adolescents.
    Taylan C; Schaaf A; Dorn C; Schmitt CP; Loos S; Kanzelmeyer N; Pape L; Müller D; Weber LT; Thumfart J
    Front Pediatr; 2022; 10():850819. PubMed ID: 35498796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma exchange and immunoadsorption for autoimmune neurologic diseases - current guidelines and future perspectives.
    Klingel R; Heibges A; Fassbender C
    Atheroscler Suppl; 2009 Dec; 10(5):129-32. PubMed ID: 20129391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transient spurious intrathecal immunoglobulin synthesis in neurological patients after therapeutic apheresis.
    Berger B; Hottenrott T; Leubner J; Dersch R; Rauer S; Stich O; Prüss H
    BMC Neurol; 2015 Dec; 15():255. PubMed ID: 26830688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurologic diseases of the central nervous system with pathophysiologically relevant autoantibodies--perspectives for immunoadsorption.
    Klingel R; Heibges A; Fassbender C
    Atheroscler Suppl; 2013 Jan; 14(1):161-5. PubMed ID: 23357159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility of pediatric plasma apheresis in intensive care settings.
    Haque A; Sher G; Hoda M; Moiz B
    Ther Apher Dial; 2014 Oct; 18(5):497-501. PubMed ID: 24674133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of immunoadsorption with the Immusorba TR-350 column on coagulation compared to plasma exchange.
    Koessler J; Kobsar A; Kuhn S; Koessler A; Yilmaz P; Weinig E; Putz E; Boeck M; Klinker E
    Vox Sang; 2015 Jan; 108(1):46-51. PubMed ID: 25131310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoadsorption and plasma exchange-Efficient treatment options for neurological autoimmune diseases.
    Boedecker SC; Luessi F; Engel S; Kraus D; Klimpke P; Holtz S; Meinek M; Marczynski P; Weinmann A; Weinmann-Menke J
    J Clin Apher; 2022 Feb; 37(1):70-81. PubMed ID: 34904748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guillain-Barré syndrome treated by membrane plasma exchange and/or immunoadsorption.
    Marn Pernat A; Buturović-Ponikvar J; Svigelj V; Ponikvar R
    Ther Apher Dial; 2009 Aug; 13(4):310-3. PubMed ID: 19695065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma exchange for the patients with dilated cardiomyopathy in children is safe and effective in improving both cardiac function and daily activities.
    Moriguchi T; Koizumi K; Matsuda K; Harii N; Goto J; Harada D; Sugawara H; Hoshiai M; Kise H; Baba A
    J Artif Organs; 2017 Sep; 20(3):236-243. PubMed ID: 28382424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing the efficacy of three techniques to reduce isoagglutinin titers in AB0 incompatible kidney transplant recipients.
    Parmentier SP; Rosenkranz E; Schirutschke H; Opgenoorth M; Quick C; Hoelig K; Rosner A; Hohenstein B; Hugo C; Passauer J
    Atheroscler Suppl; 2017 Nov; 30():253-256. PubMed ID: 29096846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency of immediate adverse effects associated with therapeutic apheresis.
    McLeod BC; Sniecinski I; Ciavarella D; Owen H; Price TH; Randels MJ; Smith JW
    Transfusion; 1999 Mar; 39(3):282-8. PubMed ID: 10204591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in the Reponses to Apheresis Therapy of Patients With 3 Histopathologically Classified Immunopathological Patterns of Multiple Sclerosis.
    Stork L; Ellenberger D; Beißbarth T; Friede T; Lucchinetti CF; Brück W; Metz I
    JAMA Neurol; 2018 Apr; 75(4):428-435. PubMed ID: 29404583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic apheresis in neurological disorders.
    Khatri BO
    Ther Apher; 1999 May; 3(2):161-71. PubMed ID: 10341392
    [No Abstract]   [Full Text] [Related]  

  • 37. Therapeutic apheresis in neurological disorders: a survey of the evidence in support of current category I and II indications for therapeutic plasma exchange.
    Weinstein R
    J Clin Apher; 2008; 23(6):196-201. PubMed ID: 18973115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Scope and application of therapeutic apheresis: Experience from a tertiary care hospital in North India.
    Sharma RR; Saluja K; Jain A; Dhawan HK; Thakral B; Marwaha N
    Transfus Apher Sci; 2011 Dec; 45(3):239-45. PubMed ID: 22036963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma exchange or immunoadsorption in patients with rapidly progressive crescentic glomerulonephritis. A Swedish multi-center study.
    Stegmayr BG; Almroth G; Berlin G; Fehrman I; Kurkus J; Norda R; Olander R; Sterner G; Thysell H; Wikström B; Wirén JE
    Int J Artif Organs; 1999 Feb; 22(2):81-7. PubMed ID: 10212042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Actual situation of lipoprotein apheresis in Saxony in 2013.
    Emmrich U; Hohenstein B; Julius U
    Atheroscler Suppl; 2015 May; 18():215-25. PubMed ID: 25936329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.